Effective empiric treatment of infertility

2006 ◽  
Vol 4 (2) ◽  
pp. 48-51
Author(s):  
H NELSON ◽  
G ADAMSON
Keyword(s):  
Empiric Treatment

A Missing Diagnosis May Call for Empiric Treatment

2009 ◽  
Vol 40 (1) ◽  
pp. 22
Author(s):  
SHARON WORCESTER
Keyword(s):  
Empiric Treatment

Empiric Treatment For COPD And Changes In Therapy After Subsequent Spirometry

2011 ◽  
Author(s):  
David H. Ramenofsky ◽  
Anne C. Melzer ◽  
Jane Uman ◽  
David H. Au
Keyword(s):  
Empiric Treatment

ROLE OF EMPIRIC TREATMENT WITH AUTOTITRATING-CPAP IN PATIENTS SUSPECTED OF HAVING OBSTRUCTIVE SLEEP APNEA

CHEST Journal ◽  
2007 ◽  
Vol 132 (4) ◽  
pp. 503B
Author(s):  
Naveen C. Akkina ◽  
Sunita Kumar ◽  
Ashok Fulambaker ◽  
Mark Cohen ◽  
Basheer Farooki ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Empiric Treatment ◽  
Obstructive Sleep

scholarly journals Bleeding and Thrombotic Adverse Events in Hospitalized Patients Under Empiric Treatment for Suspected Heparin-Induced Thrombocytopenia While Awaiting Confirmatory Testing

2021 ◽  
Vol 27 ◽  
pp. 107602962199647
Author(s):  
Kaitlyn C. Dykes ◽  
Cassandra A. Johnson ◽  
Jerald Z. Gong ◽  
Steven E. McKenzie ◽  
Holleh D. Husseinzadeh
Keyword(s):  
Adverse Events ◽  
Watchful Waiting ◽  
Prediction Models ◽  
Bleeding Event ◽  
Retrospective Chart Review ◽  
Bleeding Risk ◽  
Heparin Induced Thrombocytopenia ◽  
Empiric Treatment ◽  
Heparin Anticoagulation ◽  
Management Groups

Empiric management in suspected heparin-induced thrombocytopenia (HIT) is challenging due to imperfect prediction models, latency while awaiting test results and risks of empiric therapies. When there is high clinical suspicion for HIT, cessation of heparin and empiric non-heparin anticoagulation with FDA-approved argatroban is recommended. Alternatively off-label fondaparinux or watchful waiting have been utilized in clinical practice. Outcomes of patients empirically managed for HIT have not been compared directly in clinical trials and patients that ultimately do not have HIT are often overlooked. Clinicians need studies investigating empiric management to guide decision making in suspected HIT. In this study, adverse events (AE) were categorized and compared in patients being evaluated for HIT while undergoing empiric management by non-heparin anticoagulation with argatroban or fondaparinux, both at therapeutic or reduced doses, or watchful waiting with or without heparin. AE were defined as new thrombosis confirmed on imaging or new bleeding event after HIT was first suspected. A retrospective chart review of 312 patients tested for HIT at an academic hospital was conducted. 170 patients met inclusion criteria. Patients were excluded if the 4Ts score was < 4. The 4Ts score is a pretest probability for HIT based on thrombocytopenia degree, timing, alternative causes and presence of thrombosis. Included patients were divided according to management groups and compared with logistic regression analysis. Bleeding risk significantly differed between management groups (p = 0.002). Despite adjustment for bleeding risk, fondaparinux was associated with increased AE, (p = 0.03, OR = 5.81), while argatroban was not. There was no difference in AE based on time to initiation of empiric treatment and no advantage to reduced dosing with either anticoagulant. These findings challenge assumptions surrounding empiric HIT management.

Empiric treatment of gonorrhea and chlamydia in the emergency department

1999 ◽  
Vol 34 (4) ◽  
pp. S41-S42
Author(s):  
DR Weist ◽  
SJ Spear ◽  
JM Bartfield
Keyword(s):  
Emergency Department ◽  
Empiric Treatment

COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS HAND INFECTIONS: A SOUTH PACIFIC PERSPECTIVE — CHARACTERISTICS AND IMPLICATIONS FOR ANTIBIOTIC COVERAGE

Hand Surgery ◽  
2012 ◽  
Vol 17 (03) ◽  
pp. 317-324 ◽  
Author(s):  
Derek Buchanan ◽  
Wolfgang Heiss-Dunlop ◽  
Jon A. Mathy
Keyword(s):  
Staphylococcus Aureus ◽  
Antibiotic Treatment ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
The United States ◽  
Control Group ◽  
Methicillin Resistant ◽  
Empiric Treatment ◽  
Sensitivity Data ◽  
Culture Positive ◽  
Antibiotic Coverage

Purpose: Community acquired methicillin resistant Staphylococcus aureus (CA-MRSA) infections are reported to be increasing worldwide. In the United States when rates exceed 15% empiric treatment is suggested. The aim of our study was to determine local rates and treatment of CA-MRSA within our region. Methods: Nine hundred and forty-two patients were admitted to our service during a six-year period with culture-positive hand infections identified from operative cultures at the time of surgery. Results: Sixty-six (7.0%) patients had CA-MRSA positive cultures identified. Thirty-two (48.5%) patients were noted to have remained on antibiotic treatment that did not reflect their MRSA positive status after cultures returned. Despite this, re-admission and re-operation rates were low and comparable to our non-MRSA control group. Conclusions: Within our CA-MRSA group, current rates do not support automatic empiric treatment for CA-MRSA. Based on sensitivity data, co-trimoxazole and intravenous vancomycin are appropriate and effective antibiotic treatment within our region. Our data supports the importance of drainage of pyogenic infections in helping to resolve complicated hand infections.

scholarly journals Impact of Inappropriate Empiric Treatment of Enterobacteriaceae Urinary Tract Infection, Pneumonia and Sepsis on Hospital Outcomes

2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Marya D. Zilberberg ◽  
Brian Nathanson ◽  
Kate Sulham ◽  
Weihong Fan ◽  
Andrew F. Shorr
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Hospital Outcomes ◽  
Empiric Treatment
Sign in / Sign up

Export Citation Format

Share Document